Skip to main content
SpringerLink
Log in

Metabolite analysis of [11C]flumazenil in human plasma: Assessment as the standardized value for quantitative PET studies

  • Short Communication
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Analysis of carbon-11 labeled metabolites in plasma was carried out during positron emission tomography (PET) studies with a central benzodiazepine receptor ligand [11C]flumazenil ([11C]FMZ) in 24 human subjects (14–76 y.o.) including five normal volunteers and 19 patients with neurological disorders. Arterial plasma samples were obtained at 3, 5, 10, 15, 20, 30 and 60 min after i.v. injection of the tracer, and were analyzed by high-performance liquid chromatography. The rate of plasma [11C]FMZ degradation was associated with a large individual variation, but no significant difference was found in the degradation of [11C]FMZ either between male and female, young and old, or between normal subjects and patient groups. When the mean fraction of unchanged [11C]FMZ at each time point was used instead of individually measured metabolite data for the arterial input function, as much as a 30% error occurred in the distribution volume of the [11C]FMZ binding in the brain. These results indicate that the mean percentage of unchanged [11C]FMZ fraction in subjects cannot be used as the standardized value, and that the analysis of metabolites in plasma is necessary to determine the exact arterial input function for quantitative PET measurement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ishiwata K, Hatazawa J, Kubota K, Kameyama M, Itoh M, Matsuzawa T, et al. Metabolic fate of L-[methyl-11C]methionine in human plasma.Eur J Nucl Med 15: 665–669, 1989.

    Article  PubMed  CAS  Google Scholar 

  2. Ishiwata K, Yanai K, Iwata R, Takahashi T, Hatazawa J, Itoh M, et al. Analysis of plasma metabolites during human PET studies with three receptor ligands, [11C]YM-09151-2, [11C]doxepin and [11C]pyrilamine.Tohoku J Exp Med 178: 129–136, 1996.

    Article  PubMed  CAS  Google Scholar 

  3. Pike VW, Halldin C, Crouzel C, Barre L, Nutt DJ, Osman S, et al. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites—current status.Nucl Med Biol 20: 503–525, 1993.

    Article  PubMed  CAS  Google Scholar 

  4. Malizia AL, Richardson MP. Benzodiazepine receptors and positron emission tomography: ten years of experience. A new beginning?J Psychopharmacol 9: 355–368, 1995.

    Article  CAS  Google Scholar 

  5. Swahn C-G, Persson A, Pauli S. Metabolism of the benzodiazepine antagonist11C-Ro 15-1788 after intravenous administration in man.Human Psychopharmacol 4: 297–301, 1989.

    Article  CAS  Google Scholar 

  6. Loc’h C, Hantraye Ph, Khalili-Varasteh M, Mazière B, Delforge J, Brouillet E, et al. [11C]-Flumazenil metabolites: measurements of unchanged ligand in plasma using thin layer chromatography and rapid liquid chromatography.J Label Compds Radiopharm 30: 234, 1990.

    Google Scholar 

  7. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilboum MR, Kuhl DE. Parametricin vivo imaging of benzodiazepine receptor distribution in human brain.Ann Neurol 30: 663–672, 1991.

    Article  PubMed  CAS  Google Scholar 

  8. Barre L, Debruyne D, Abadie P, Moulin M, Baron JC. A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans.Appl Radiat Isot 42: 435–439, 1991.

    Article  CAS  Google Scholar 

  9. Debruyne D, Abadie P, Barre L, Albessard F, Moulin M, Zarifian E, et al. Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C]Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.Eur J Drug Metab Pharmacokinet 16: 141–152, 1991.

    Article  PubMed  CAS  Google Scholar 

  10. Pauli S, Liljequist S, Farde L, Swahn C-G, Halldin C, Litton J-E, et al. PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil.Psychopharmacology 107: 180–185, 1992.

    Article  PubMed  CAS  Google Scholar 

  11. Delforge J, Syrota A, Bottlaender M, Varastet M, Loc’h C, Bendriem B, et al. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches.J Cereb Blood Flow Metab 13: 454–468, 1993.

    PubMed  CAS  Google Scholar 

  12. Suzuki K, Inoue O, Hashimoto K, Yamasaki T, Kuchiki M, Tamate K. Computer-controlled large scale production of high specific activity [11C]RO 15-1788 for PET studies of benzodiazepine receptors.Appl Radiat Isot 36: 971–976, 1985.

    Article  CAS  Google Scholar 

  13. Ishiwata K, Seki H, Ishii K, Ishii S, Nozaki T, Senda M. Synthesis andin vivo evaluation of [11C]semotiadil, a benzothiazine calcium antagonist.Appl Radiat Ihot 45: 439–443, 1994.

    Article  CAS  Google Scholar 

  14. Iida H, Miura S, Kanno I, Murakami M, Yamamoto S, Amano M. Design and evaluation of Headtome-IV, a whole-body positron emission tomography.IEEE Trans Nucl Sci NS-37: 1006–1010, 1989.

    Article  Google Scholar 

  15. Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.J Cereb Blood Flow Metab 11: 735–744, 1991.

    PubMed  CAS  Google Scholar 

  16. Millet P, Delforge J, Mauguiere F, Pappata S, Cinotti L, Frouin V, et al. Parameter and index images of benzodiazepine receptor concentration in the brain.J Nucl Med 36: 1462–1472, 1995.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Positron Medical Center, Tokyo Metropolitan Institute of Gerontology, 1-1 Nakacho, Itabashi, 173-0022, Tokyo, Japan

    Kiichi Ishiwata, Takehito Itou, Takamitsu Yamada, Kenji Ishii, Toru Sasaki, Kei-ichi Oda, Hinako Toyama & Michio Senda

  2. Second Department of Internal Medicine, Nippon Medical School, Japan

    Masashi Ohyama & Masahiro Mishina

  3. Department of Neurosurgery, Tokyo Medical and Dental University, Japan

    Tadashi Nariai

Authors
  1. Kiichi Ishiwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takehito Itou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masashi Ohyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takamitsu Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masahiro Mishina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenji Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tadashi Nariai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Toru Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kei-ichi Oda
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hinako Toyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Michio Senda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kiichi Ishiwata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishiwata, K., Itou, T., Ohyama, M. et al. Metabolite analysis of [11C]flumazenil in human plasma: Assessment as the standardized value for quantitative PET studies. Ann Nucl Med 12, 55–59 (1998). https://doi.org/10.1007/BF03165418

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03165418

Key words

Search

Navigation